Approaches to dimensionality reduction in proteomic biomarker studies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18310106.
- Also identified by DOI 10.1093/bib/bbn005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mass-spectra based proteomic profiles have received widespread attention as potential tools for biomarker discovery and early disease diagnosis. A major data-analytical problem involved is the extremely high dimensionality (i.e. number of features or variables) of proteomic data, in particular when the sample size is small. This article reviews dimensionality reduction methods that have been used in proteomic biomarker studies. It then focuses on the problem of selecting the most appropriate method for a specific task or dataset, and proposes method combination as a potential alternative to single-method selection. Finally, it points out the potential of novel dimension reduction techniques, in particular those that incorporate domain knowledge through the use of informative priors or causal inference.
Medical subject headings
- Biomarkers
- Electronic Data Processing
- Proteomics
- Research